Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Maria Gordon
Senior Manager, Clinical Research
Senior VP Health Sciences
Overview
Research
More
Collaboration
(27)
Franz Rischard
Mutual work: 6 Proposals﹒4 Grants
Collaboration Details
Alma Leon
Mutual work: 1 Supervisor﹒1 Grant
Collaboration Details
Lawrence Mandarino
Mutual work: 1 Grant
Collaboration Details
Francisco Moreno
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Janet Funk
Mutual work: 1 Grant
Collaboration Details
Page 1 of 6
Previous page
Next page
Grants
(12)
A Phase 4, Prospective, Multicenter, Single-Arm Study of a Mean Pulmonary Artery Pressure-Targeted Approach with Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Patient
Active
·
2023
·
$0 / $509.1K
·
External
undefined (CD)
pulmonary hypertension,
right ventricular remodeling,
treprostinil therapy,
pulmonary artery pressure
A Phase 2b, Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Treprostinil Palmitil Inhalation Powder (TPIP)
Active
·
2023
·
$0 / $450K
·
External
undefined (CD)
pharmacokinetics,
drug safety,
clinical trial,
pulmonary hypertension,
drug efficacy
IMPAHCT-FUL: A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002
Active
·
2023
·
$0 / $436.7K
·
External
undefined (CD)
pulmonary arterial hypertension,
long-term safety,
av-101
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Bi 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (Pf-ilds)
Active
·
2023
·
$0 / $272K
·
External
undefined (CD)
clinical trials,
interstitial lung diseases,
drug efficacy,
patient safety,
progressive fibrosing
A Phase 2, Randomized, Double-blinded, Placebo-controlled, Parallel Group Study Evaluating the Efficacy and Safety of Amiselimod (Mt-1303) in Subjects With Mild to Moderate Ulcerative Colitis (UC)
Active
·
2023
·
$0 / $240.8K
·
External
undefined (CD)
pharmacology,
gastroenterology,
clinical trials,
immunology,
drug safety
Page 1 of 3
Previous page
Next page